Jon P Stonehouse is Chief Executive Officer of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 1.32 Million shares of BCRX, which is worth approximately $9.37 Million. The most recent transaction as insider was on Dec 14, 2021, when has been sold 123,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.32M
7.39% 3M change
7.39% 12M change
Total Value Held $9.37 Million

Jon P Stonehouse Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2021
BUY
Grant, award, or other acquisition
-
123,000 Added 12.0%
901,602 Common Stock
Sep 01 2021
SELL
Bona fide gift
-
10,000 Reduced 1.27%
778,602 Common Stock
Dec 15 2020
SELL
Open market or private sale
$1,117,193 $8.32 p/Share
134,278 Reduced 14.62%
784,086 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$557,254 $4.15 p/Share
134,278 Added 12.76%
918,364 Common Stock

Also insider at

BLCM
BELLICUM PHARMACEUTICALS, INC Healthcare
MTSR
Metsera, Inc.
JPS

Jon P Stonehouse

Chief Executive Officer
Houston, TX

Track Institutional and Insider Activities on BCRX

Follow BIOCRYST PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX